Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The polyamine binding site refers to specific regulatory regions on the N-methyl-D-aspartate (NMDA) receptor and inwardly rectifying potassium (Kir) channels that interact with endogenous polyamines such as spermine and spermidine [7, 8]. On the NMDA receptor, these sites act as allosteric modulators; at low concentrations, polyamines enhance receptor activity by increasing the affinity for glycine and the frequency of channel opening, while at higher concentrations, they can exert an inhibitory effect [10, 11]. In Kir channels, polyamines function as intracellular pore blockers, providing the molecular basis for inward rectification by obstructing the channel at depolarized membrane potentials [3, 15]. These sites are critical for regulating synaptic plasticity and neuronal excitability, and their dysregulation is implicated in neurodegenerative diseases, stroke, and chronic pain [1, 21]. Pharmacological agents targeting these sites, such as the antagonist arcaine or the NR2B-selective modulator ifenprodil, are investigated for their neuroprotective potential and ability to mitigate excitotoxicity [10, 11]. Additionally, the elevated polyamine levels observed in many cancers make these binding sites and the associated transport systems potential targets for oncological interventions [2, 13]. Recent research has also identified potential polyamine binding pockets in viral proteins like the SARS-CoV-2 ORF3a, suggesting a role in viral-host interactions [16].
Allosteric modulation of NMDA receptor activity and voltage-dependent pore blockade of inwardly rectifying potassium channels.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-methyl-D-aspartate receptor polyamine site (NMDAR polyamine site).